Literature DB >> 21412131

Relationship of adipokines with insulin sensitivity in African Americans.

Maria P Martinez Cantarin1, Scott W Keith, Stephanie Deloach, Yonghong Huan, Bonita Falkner.   

Abstract

INTRODUCTION: Cytokines produced by adipose tissue, including adiponectin, have been associated with metabolic abnormalities. The purpose of this study was to examine the relationship of insulin sensitivity measured by euglycemic hyperinsulinemic insulin clamp with plasma adiponectin and other adipokines in young adult African Americans.
METHODS: Participants were healthy African Americans. Anthropometric measures, blood pressure, an oral glucose tolerance test and an euglycemic hyperinsulinemic insulin clamp were performed. Insulin sensitivity measurements were adjusted for percentage of fat mass. Plasma concentrations of adiponectin, plasminogen activator inhibitor-1 (PAI-1) and interleukin-6 (IL-6) were assayed on plasma from fasting blood samples. Pearson correlation coefficients and multiple regression models were fitted to assess the association between glucose sensitivity and cytokines.
RESULTS: In univariate analysis, there were statistically significant correlations of plasma adiponectin level (r = 0.19, P = 0.004), PAI-1 (r = -0.19, P = 0.020) and IL-6 (r = -0.24, P < 0.001) with measures of insulin sensitivity after adjustment for both fat mass and insulin clamp concentration. In multivariate analysis, adiponectin [geometric mean ratios (GMR) 1.15, P = 0.007], PAI-1 (GMR 0.998, P = 0.021) and body mass index (GMR 0.95, P < 0.001) were each independently associated with insulin sensitivity. For IL-6, there was no significant association with insulin sensitivity independent of obesity.
CONCLUSION: These data show a significant and independent positive correlation of adiponectin with insulin sensitivity. The relationship of IL-6 with insulin sensitivity seems to be dependent on adiposity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21412131      PMCID: PMC3134542          DOI: 10.1097/MAJ.0b013e3182112bcd

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  48 in total

1.  Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men.

Authors:  Jan Frystyk; Christian Berne; Lars Berglund; Karin Jensevik; Allan Flyvbjerg; Björn Zethelius
Journal:  J Clin Endocrinol Metab       Date:  2006-11-21       Impact factor: 5.958

Review 2.  Inflammation and insulin resistance.

Authors:  Steven E Shoelson; Jongsoon Lee; Allison B Goldfine
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

3.  Clustering of insulin resistance with vascular dysfunction and low-grade inflammation in type 2 diabetes.

Authors:  Andrea Natali; Elena Toschi; Stephanie Baldeweg; Demetrio Ciociaro; Stefania Favilla; Luigi Saccà; Ele Ferrannini
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

Review 4.  The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease.

Authors:  Steven M Haffner
Journal:  Am J Cardiol       Date:  2005-12-05       Impact factor: 2.778

5.  Adiponectin and leptin in African Americans.

Authors:  Robert V Considine; Ahalya Premkumar; James C Reynolds; Nancy G Sebring; Madia Ricks; Anne E Sumner
Journal:  Obesity (Silver Spring)       Date:  2008-02       Impact factor: 5.002

Review 6.  Obesity, inflammation, and atherosclerosis.

Authors:  Viviane Z Rocha; Peter Libby
Journal:  Nat Rev Cardiol       Date:  2009-04-28       Impact factor: 32.419

7.  Insulin resistance predicts future deterioration of glucose tolerance in nondiabetic young African Americans.

Authors:  Yonghong Huan; Harvey Kushner; Bonita Falkner
Journal:  Metabolism       Date:  2009-05       Impact factor: 8.694

8.  Insulin resistance, serum adiponectin, and proinflammatory markers in young subjects with the metabolic syndrome.

Authors:  Irina Kowalska; Marek Straczkowski; Agnieszka Nikolajuk; Agnieszka Adamska; Monika Karczewska-Kupczewska; Elzbieta Otziomek; Ida Kinalska; Maria Gorska
Journal:  Metabolism       Date:  2008-11       Impact factor: 8.694

9.  Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program.

Authors:  Kieren J Mather; Tohru Funahashi; Yuji Matsuzawa; Sharon Edelstein; George A Bray; Steven E Kahn; Jill Crandall; Santica Marcovina; Barry Goldstein; Ronald Goldberg
Journal:  Diabetes       Date:  2008-01-11       Impact factor: 9.461

10.  Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults.

Authors:  Katherine M Flegal; John A Shepherd; Anne C Looker; Barry I Graubard; Lori G Borrud; Cynthia L Ogden; Tamara B Harris; James E Everhart; Nathaniel Schenker
Journal:  Am J Clin Nutr       Date:  2008-12-30       Impact factor: 7.045

View more
  3 in total

1.  Impact of vitamin D supplementation on inflammatory markers in African Americans: results of a four-arm, randomized, placebo-controlled trial.

Authors:  Paulette D Chandler; Jamil B Scott; Bettina F Drake; Kimmie Ng; Joann E Manson; Nader Rifai; Andrew T Chan; Gary G Bennett; Bruce W Hollis; Edward L Giovannucci; Karen M Emmons; Charles S Fuchs
Journal:  Cancer Prev Res (Phila)       Date:  2013-12-10

Review 2.  Hyperinsulinemia, insulin resistance, vitamin D, and colorectal cancer among whites and African Americans.

Authors:  Chung-Jyi Tsai; Edward L Giovannucci
Journal:  Dig Dis Sci       Date:  2012-05-06       Impact factor: 3.199

3.  Racial Disparities in the Pathogenesis of Type 2 Diabetes and its Subtypes in the African Diaspora: A New Paradigm.

Authors:  Trudy R Gaillard; Kwame Osei
Journal:  J Racial Ethn Health Disparities       Date:  2015-05-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.